Myocardial BOLD imaging at 3 T using quantitative T2: Application in a myocardial infarct model

Magnetic Resonance in Medicine

Volumn 66, Issue 6, 2011, Pages 1739-1747

  Ghugre, Nilesh R ^a   Ramanan, Venkat ^a   Pop, Mihaela ^a   Yang, Yuesong ^a   Barry, Jennifer ^a   Qiang, Beiping ^a   Connelly, Kim A ^b   Dick, Alexander J ^a,c   Wright, Graham A ^a,d  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

3 T; acute myocardial infarction; BOLD

Indexed keywords

CARDIOLOGY; MAMMALS; OXYGEN;

ACUTE MYOCARDIAL INFARCTION; BLOOD OXYGEN LEVEL DEPENDENTS; BOLD; CARDIOVASCULAR DYSFUNCTION; CORONARY FLOW RESERVES; LEFT VENTRICULAR REMODELING; THERAPEUTIC STRATEGY; VASODILATORY FUNCTIONS;

BLOOD;

GADOLINIUM PENTETATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BOLD SIGNAL; DIFFUSION WEIGHTED IMAGING; FEMALE; HEART INFARCTION; HEART MUSCLE; HEART VENTRICLE REMODELING; IMAGE ANALYSIS; NON INVASIVE MEASUREMENT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SCANNER; QUANTITATIVE ANALYSIS; SWINE; VASODILATATION;

EID: 81355161583     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.22972     Document Type: Article

References (30)

1. Pfeffer MA, Braunwald E,. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 1990; 81: 1161-1172.
2. Jaffe R, Charron T, Puley G, Dick A, Strauss BH,. Microvascular obstruction and the no-reflow phenomenon after percutaneous coronary intervention. Circulation 2008; 117: 3152-3156.
3. Ishihara M, Sato H, Tateishi H, Kawagoe T, Yoshimura M, Muraoka Y,. Impaired coronary flow reserve immediately after coronary angioplasty in patients with acute myocardial infarction. Br Heart J 1993; 69: 288-292.
4. Uren NG, Crake T, Lefroy DC, de Silva R, Davies GJ, Maseri A,. Reduced coronary vasodilator function in infarcted and normal myocardium after myocardial infarction. N Engl J Med 1994; 331: 222-227.
5. Ishihara M, Sato H, Tateishi H, Kawagoe T, Shimatani Y, Kurisu S, Sakai K,. Time course of impaired coronary flow reserve after reperfusion in patients with acute myocardial infarction. Am J Cardiol 1996; 78: 1103-1108.
6. Takahashi T, Hiasa Y, Ohara Y, Yamaguchi K, Tomokane T, Ogura R, Ogata T, Yuba K, Suzuki N, Hosokawa S, Kishi K, Ohtani R,. Usefulness of coronary flow reserve immediately after primary coronary stenting in predicting wall motion recovery in patients with anterior wall acute myocardial infarction. Am J Cardiol 2004; 94: 1033-1037.
7. Friedrich MG, Niendorf T, Schulz-Menger J, Gross CM, Dietz R,. Blood oxygen level-dependent magnetic resonance imaging in patients with stress-induced angina. Circulation 2003; 108: 2219-2223.
8. Wacker CM, Hartlep AW, Pfleger S, Schad LR, Ertl G, Bauer WR,. Susceptibility-sensitive magnetic resonance imaging detects human myocardium supplied by a stenotic coronary artery without a contrast agent. J Am Coll Cardiol 2003; 41: 834-840.
9. Dharmakumar R, Arumana JM, Tang R, Harris K, Zhang Z, Li D,. Assessment of regional myocardial oxygenation changes in the presence of coronary artery stenosis with balanced SSFP imaging at 3.0 T: theory and experimental evaluation in canines. J Magn Reson Imaging 2008; 27: 1037-1045.
10. 2-prepared steady-state free-precession magnetic resonance imaging. Circulation 2004; 110: 1284-1290.
11. Foltz WD, Huang H, Fort S, Wright GA,. Vasodilator response assessment in porcine myocardium with magnetic resonance relaxometry. Circulation 2002; 106: 2714-2719.
12. Zhang H, Gropler RJ, Li D, Zheng J,. Assessment of myocardial oxygen extraction fraction and perfusion reserve with BOLD imaging in a canine model with coronary artery stenosis. J Magn Reson Imaging 2007; 26: 72-79.
13. Stainsby JA, Wright GA,. Monitoring blood oxygen state in muscle microcirculation with transverse relaxation. Magn Reson Med 2001; 45: 662-672.
14. McCommis KS, Goldstein TA, Zhang H, Misselwitz B, Gropler RJ, Zheng J,. Quantification of myocardial blood volume during dipyridamole and doubtamine stress: a perfusion CMR study. J Cardiovasc Magn Reson 2007; 9: 785-792.
15. Wright GA, Hu BS, Macovski A,. 1991 I.I. Rabi award. Estimating oxygen saturation of blood in vivo with MR imaging at 1.5 T. J Magn Reson Imaging 1991; 1: 275-283.
16. Lee T, Stainsby JA, Hong J, Han E, Brittain JH, Wright GA,. Blood relaxation properties at 3 T-effects of blood oxygen saturation. In: Proceedings of 11th Annual Meeting of ISMRM, Toronto, ON, Canada, 2003. No. 131.
17. Brooks RA, Di Chiro G,. Magnetic resonance imaging of stationary blood: a review. Med Phys 1987; 14: 903-913.
18. Reeder SB, Faranesh AZ, Boxerman JL, McVeigh ER,. In vivo measurement of T 2 * and field inhomogeneity maps in the human heart at 1.5 T. Magn Reson Med 1998; 39: 988-998.
19. Raza JA, Reeves WC, Movahed A,. Pharmacological stress agents for evaluation of ischemic heart disease. Int J Cardiol 2001; 81: 157-167.
20. Karamitsos TD, Leccisotti L, Arnold JR, Recio-Mayoral A, Bhamra-Ariza P, Howells RK, Searle N, Robson MD, Rimoldi OE, Camici PG, Neubauer S, Selvanayagam JB,. Relationship between regional myocardial oxygenation and perfusion in patients with coronary artery disease: insights from cardiovascular magnetic resonance and positron emission tomography. Circ Cardiovasc Imaging 2010; 3: 32-40.
21. Jahnke C, Gebker R, Manka R, Schnackenburg B, Fleck E, Paetsch I,. Navigator-gated 3D blood oxygen level-dependent CMR at 3.0-T for detection of stress-induced myocardial ischemic reactions. JACC Cardiovasc Imaging 2010; 3: 375-384.
22. Manka R, Paetsch I, Schnackenburg B, Gebker R, Fleck E, Jahnke C,. BOLD cardiovascular magnetic resonance at 3.0 Tesla in myocardial ischemia. J Cardiovasc Magn Reson 2010; 12: 54.
23. Reimer KA, Lowe JE, Rasmussen MM, Jennings RB,. The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs. Circulation 1977; 56: 786-794.
24. Hedstrom E, Engblom H, Frogner F, Astrom-Olsson K, Ohlin H, Jovinge S, Arheden H,. Infarct evolution in man studied in patients with first-time coronary occlusion in comparison to different species-implications for assessment of myocardial salvage. J Cardiovasc Magn Reson 2009; 11: 38.
25. Fishbein MC, Maclean D, Maroko PR,. The histopathologic evolution of myocardial infarction. Chest 1978; 73: 843-849.
26. MacLean MJ, Biro GP,. Time course of myocardial bloodflow changes during healing of myocardial infarct in pigs. Can J Cardiol 1992; 8: 749-755.
27. McAlpine HM, Morton JJ, Leckie B, Rumley A, Gillen G, Dargie HJ,. Neuroendocrine activation after acute myocardial infarction. Br Heart J 1988; 60: 117-124.
28. Shah BR, Cowper PA, O'Brien SM, Jensen N, Drawz M, Patel MR, Douglas PS, Peterson ED,. Patterns of cardiac stress testing after revascularization in community practice. J Am Coll Cardiol 2010; 56: 1328-1334.
29. Tomai F, Ribichini F, Ghini AS, Ferrero V, Ando G, Vassanelli C, Romeo F, Crea F, Chiariello L,. Elevated C-reactive protein levels and coronary microvascular dysfunction in patients with coronary artery disease. Eur Heart J 2005; 26: 2099-2105.
30. Givertz MM, Braunwald E,. Neurohormones in heart failure: predicting outcomes, optimizing care. Eur Heart J 2004; 25: 281-282.